| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |